Titre original:
A Phase 2, double-blind, placebo-controlled, randomized study to compare the efficacy and safety of sotatercept (ACE-011) versus placebo when added to standard of care for the treatment of pulmonary arterial hypertension (PAH)
Indication (pathologie):
Pulmonary arterial hypertension
Identifiant SNOMED-CT:
11399002
Identifiant EUDRA-CT:
2017-004738-27
Phase de l'étude:
Phase II
Recrutement:
Ouvert
Service:
Investigateur principal:
Vachiery Jean Luc
Sponsor:
Acceleron Pharma Inc.
Tél contact:
02 555 3907
Email contact:
Adresse hôpital:
Cliniques Universitaires de Bruxelles Hôpital Erasme
Route de Lennik 808,1070 Bruxelles, Belgique